Anevski Peter reported option exercise involving 126,204 derivative units of Progyny, Inc. at $0.00 for $0 on Nov 9, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
CHIEF EXECUTIVE OFFICER
CHIEF EXECUTIVE OFFICER
Filed Nov 9, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
126,204Stock Option (Right to Buy)
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
342,503Direct
Trade date
Nov 9, 2026Option exercise
Filed
Nov 9, 2026, 9:57 PM ET1-day reporting delay
Accession
0001551306-26-000176Code M · Transaction 396655
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 5, 2026Option exercise3,400$0.00$0Trade 396654
Nov 5, 2026Option exercise3,400$0.91$3,094Trade 396648
Nov 9, 2026Option exercise126,204$0.91$114,845.64Trade 396651
Nov 5, 2026Sell3,400$35.23−$119,773.84Trade 396649
Nov 5, 2026Sell8,539$35.09−$299,638.63Trade 396650
Nov 9, 2026Sell126,204$35.73−$4,508,726.24Trade 396652
Nov 9, 2026Sell35,104$35.73−$1,254,114.97Trade 396653
8 transaction rows in this filing. Joint filers share the same rows.

PGNY price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
PGNY · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 17, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago −22%1w ago −18%1d ago −3.1%
Returns since7d30d90d180d1y

Footnotes in full

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 2, 2026. F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote F5: These options are fully vested and exercisable.